Major Vessel and Vascular Disorders

Pulmonary Hypertension (PH)

Causes (WHO classification)

1.    Pulmonary arterial hypertension (PAH)

o    Idiopathic, connective tissue diseases (e.g., systemic sclerosis), HIV, portal hypertension

2.    Left heart disease

o    LV dysfunction, mitral/aortic valve disease

3.    Lung diseases and hypoxia

o    COPD, ILD, OSA

4.    Chronic thromboembolic pulmonary hypertension (CTEPH)

5.    Miscellaneous (e.g., sarcoidosis)

Clinical features

•    Dyspnoea, fatigue, syncope

•    Loud P2, right ventricular heave

•    Tricuspid regurgitation murmur, raised JVP

Investigations

•    Echo: RV dilatation, elevated pulmonary pressures

•    Right heart catheterisation: gold standard for diagnosis

Treatment

•    Underlying cause

•    PAH-specific: endothelin receptor antagonists (bosentan), PDE-5 inhibitors (sildenafil), prostacyclin analogues


Pulmonary Embolism (PE)

Clinical presentation

•    Sudden-onset dyspnoea, pleuritic chest pain, haemoptysis

•    Tachycardia, hypoxia, possible hypotension if massive

Diagnosis

•    Wells score (clinical probability)

•    D-dimer (if low-intermediate probability)

•    CT pulmonary angiogram (CTPA): gold standard

Treatment

•    LMWH (first-line)

•    DOACs (e.g., apixaban, rivaroxaban) or warfarin after initial anticoagulation

•    Thrombolysis if massive PE with haemodynamic instability


Deep Vein Thrombosis (DVT)

Risk factors

•    Virchow's triad: stasis (immobility), hypercoagulability (malignancy, OCP, thrombophilia), endothelial injury (surgery)

Clinical features

•    Unilateral leg swelling, pain, warmth

Diagnosis

•    Wells score

•    Proximal leg vein ultrasound (first-line)

Treatment

•    Anticoagulation (as for PE)

•    Compression stockings after resolution to prevent post-thrombotic syndrome


Systemic Hypertension

Classification

•    Essential (90–95%)

•    Secondary

o    Renal artery stenosis (young, flash pulmonary oedema)

o    Primary hyperaldosteronism (Conn’s): hypertension + hypokalaemia

o    Phaeochromocytoma: paroxysmal HTN, headache, palpitations, sweating

o    Cushing’s syndrome, thyroid disorders

Targets

•    <140/90 mmHg (clinic)

•    <130/80 mmHg if CKD, diabetes, or target organ damage

First-line treatment

•    <55 years or diabetic: ACE inhibitor

•    55 or Afro-Caribbean: CCB


Aortic Dissection

Presentation

•    Sudden, severe tearing chest/back pain

•    Pulse deficits, asymmetrical BP

•    New aortic regurgitation murmur

Classification

•    Stanford A: ascending ± descending surgical emergency

•    Stanford B: descending only medical therapy unless complications

Diagnosis

•    CT angiogram (gold standard)

•    CXR: widened mediastinum

Treatment

•    Control BP (IV labetalol), pain control

•    Surgery for type A


Peripheral Arterial Disease (PAD)

Features

•    Intermittent claudication (pain on exertion, relieved by rest)

•    Critical limb ischaemia: rest pain, ulcers, gangrene

•    Reduced/absent pulses

Diagnosis

•    Ankle–brachial index (ABI):

o    <0.9 diagnostic of PAD

o    <0.5 indicates severe ischaemia

Management

•    Smoking cessation

•    Antiplatelet therapy, statin

•    Supervised exercise program

•    Revascularisation (angioplasty/bypass) if severe


Carotid Artery Disease

Risk

•    TIA or stroke from emboli

Intervention

•    Carotid endarterectomy:

o    Symptomatic stenosis ≥70% (NASCET criteria)

o    Consider 50–69% if high risk


Extra Revision Pearls

•    Loud P2 clue PH (esp. in young with CTD)

•    RV heave clue chronic cor pulmonale, PH

•    Stanford A clue surgery always; can cause tamponade, AR

•    ABI <0.5 clue limb-threatening ischaemia

•    Conn’s clue HTN + low K⁺; high aldosterone, low renin

•    Phaeochromocytoma clue episodic triad + 24h urinary metanephrines

•    Hypertensive urgency vs emergency end-organ damage defines emergency

————————————————————————————————————————————————————————————————————————————————————————————————————————-

Author & Educational Disclaimer


Author:

Dr Phillip Cockrell BM FRCP DipClinEd


Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.


He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.


Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.


Purpose of this content:

The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.


Medical disclaimer:

This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.